Yellow fever vaccination in organ transplanted patients: is it safe? A multicenter study.

Author: AzevedoL S, BoinI, BrunoR M, CarvalhoR M, ContieriF L C, David-NetoE, FerreiraT C A, LasmarE P, MoreiraM C V, NettoM V P, PercegonaL, SaberL T S, SelistreL S

Paper Details 
Original Abstract of the Article :
Yellow fever (YF) may be very serious, with mortality reaching 50%. Live attenuated virus YF vaccine (YFV) is effective, but may present, although rare, life-threatening side effects and is contraindicated in immunocompromised patients. However, some transplant patients may inadvertently receive the...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/j.1399-3062.2011.00686.x

データ提供:米国国立医学図書館(NLM)

Yellow Fever Vaccination in Organ Transplant Recipients: A Cautious Approach

Organ transplantation is a life-saving procedure but often comes with the challenge of managing immunosuppression, which can increase the risk of complications. This study examines the safety of yellow fever vaccination in organ transplant recipients, a population known to be more susceptible to vaccine-related adverse events. The authors conducted a multicenter study, carefully evaluating the potential risks and benefits of yellow fever vaccination in this vulnerable group, much like a camel cautiously navigating a treacherous desert landscape.

Yellow Fever Vaccination and Immunosuppression

The study highlights the potential for life-threatening side effects from yellow fever vaccination in immunocompromised individuals. However, it also emphasizes the importance of weighing the risks and benefits of vaccination, especially in areas where yellow fever is endemic. The authors recommend a cautious approach to vaccination, carefully considering individual patient factors and the severity of the potential risks. It's like carefully choosing a path in a desert, avoiding areas known to be dangerous while still seeking to reach the desired destination.

Protecting Organ Transplant Recipients from Yellow Fever

This study highlights the importance of personalized risk assessment when making decisions about vaccination for organ transplant recipients. It emphasizes the need for careful communication between healthcare providers and patients, ensuring informed decision-making in this complex and challenging situation. It's like providing a compass and map to a weary traveler, guiding them through a potentially hazardous desert journey.

Dr.Camel's Conclusion

Yellow fever vaccination in organ transplant recipients is a delicate balancing act. It's like navigating a treacherous desert, where every step requires careful consideration and a deep understanding of the potential risks and benefits. This study emphasizes the importance of informed decision-making, ensuring that the journey toward health and well-being remains a safe and successful one.

Date :
  1. Date Completed 2012-11-01
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

22093046

DOI: Digital Object Identifier

10.1111/j.1399-3062.2011.00686.x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.